Capital Performance Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,283
Closed -$312K 377
2026
Q1
$312K Sell
7,283
-994
-12% -$42.7K 0.02% 319
2025
Q4
$363K Buy
8,277
+2,072
+33% +$85.7K 0.03% 273
2025
Q3
$256K Buy
6,205
+487
+9% +$19.6K 0.04% 253
2025
Q2
$252K Buy
5,718
+105
+2% +$4.2K 0.05% 196
2025
Q1
$207K Buy
+5,613
New +$200K 0.05% 238
2024
Q4
Sell
-2,358
Closed -$61.2K 993
2024
Q3
$61.2K Buy
+2,358
New +$58.6K 0.02% 296

Other funds holding EXEL

Capital Performance Advisors's EXEL Position: Q2 2026 in Review

Capital Performance Advisors sold out of Exelixis (EXEL) in Q2 2026, closing a stake of 7,283 shares — an estimated $312K sold.

Capital Performance Advisors first reported a position in EXEL in Q3 2024 and held it in 6 quarters. The position peaked at $363K in Q4 2025. 756 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Capital Performance Advisors reported no remaining Exelixis position as of Q2 2026 after selling out during the quarter.
  • Capital Performance Advisors sold 7,283 Exelixis shares in Q2 2026, an estimated $312K.
  • Capital Performance Advisors first reported a position in Exelixis in Q3 2024 and held it in 6 quarters.
  • Capital Performance Advisors's Exelixis position peaked at $363K in Q4 2025.
  • 756 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Capital Performance Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.